Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CRISPR01:59

CRISPR

52.7K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.7K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

140
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
140
What is Genetic Engineering?00:49

What is Genetic Engineering?

74.6K
Overview
74.6K
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

7.9K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
7.9K
Homologous Recombination02:31

Homologous Recombination

50.8K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mind the Trap: Humanization, Techno-Moral Change and the Ethics of Conversational AI.

The American journal of bioethics : AJOB·2026
Same author

Digital bioethics: exploring an emerging field.

Medicine, health care, and philosophy·2026
Same author

An interview study on socially assistive robots and professional care relationships.

Nursing ethics·2026
Same author

The Potential Harms of AI Psychotherapy: A Fear as Old as ELIZA.

The American journal of bioethics : AJOB·2026
Same author

Ethical aspects of the use of social robots in caring for older people - a systematic qualitative review.

Medicine, health care, and philosophy·2026
Same author

The Doctors, Their Patients, and the Symptom Checker App: Qualitative Interview Study With General Practitioners in Germany.

JMIR human factors·2024

Related Experiment Video

Updated: Aug 20, 2025

Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development
09:37

Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development

Published on: March 5, 2017

13.2K

Initial heritable genome editing: mapping a responsible pathway from basic research to the clinic.

Robert Ranisch1,2, Katharina Trettenbach3,4, Gardar Arnason4,5

  • 1Junior Professorship for Medical Ethics with a Focus on Digitization, Faculty of Health Sciences Brandenburg, University of Potsdam, Am Mühlberg 9, 14476, Potsdam, Golm, Germany. ranisch@uni-potsdam.de.

Medicine, Health Care, and Philosophy
|November 22, 2022
PubMed
Summary

Responsible human germline genome editing requires careful ethical consideration. This paper examines key ethical issues and proposed requirements for initial clinical applications of CRISPR in reproductive medicine.

Keywords:
CRISPRFirst-in-human trialsGermline interventionsHeritable genome editingReproductionResearch ethicsTranslational ethics

More Related Videos

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
09:51

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

34.2K
Genome Editing in Mammalian Cell Lines using CRISPR-Cas
07:56

Genome Editing in Mammalian Cell Lines using CRISPR-Cas

Published on: April 11, 2019

22.0K

Related Experiment Videos

Last Updated: Aug 20, 2025

Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development
09:37

Genome Editing and Directed Differentiation of hPSCs for Interrogating Lineage Determinants in Human Pancreatic Development

Published on: March 5, 2017

13.2K
Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms
09:51

Enhanced Genome Editing with Cas9 Ribonucleoprotein in Diverse Cells and Organisms

Published on: May 25, 2018

34.2K
Genome Editing in Mammalian Cell Lines using CRISPR-Cas
07:56

Genome Editing in Mammalian Cell Lines using CRISPR-Cas

Published on: April 11, 2019

22.0K

Area of Science:

  • Biomedical Ethics
  • Reproductive Medicine
  • Genomic Science

Background:

  • The 2018 Hong Kong Summit highlighted the need for ethical guidelines following the controversial birth of gene-edited infants.
  • Current scientific and public discourse emphasizes responsible pathways for human germline genome editing.
  • CRISPR technology presents novel challenges in reproductive medicine.

Purpose of the Study:

  • To contribute to the ethical discussion on human germline genome editing.
  • To explore key ethical issues in the initial clinical applications of CRISPR in reproductive medicine.
  • To outline challenges distinguishing germline editing from conventional clinical treatments.

Main Methods:

  • Review of current discussions on clinical applications of human germline genome editing.
  • Analysis of specific challenges associated with germline genome editing interventions.
  • Examination of proposed ethical requirements for heritable genome editing.

Main Results:

  • Germline genome editing presents unique ethical challenges compared to standard clinical interventions.
  • Key ethical requirements include absence of alternatives, robust preclinical data, informed consent, safety, and long-term follow-up.
  • A structured ethical framework is crucial for responsible advancement.

Conclusions:

  • Establishing clear ethical requirements is paramount before clinical application of human germline genome editing.
  • A cautious and deliberative approach is necessary to navigate the complexities of reproductive gene editing.
  • Ongoing dialogue and robust ethical oversight are essential for public trust and scientific integrity.